furosemide has been researched along with Infant, Premature, Diseases in 69 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 mg of nebulized furosemide per kilogram of body weight on pulmonary functions were studied in eight preterm infants with bronchopulmonary dysplasia who were supported by mechanical ventilation." | 9.07 | Nebulized furosemide in infants with bronchopulmonary dysplasia. ( Ajayi, OA; Luayon, M; Pildes, RS; Rastogi, A, 1994) |
| "To review the efficacy and safety of inhaled furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia (BPD) in preterm neonates receiving ventilator and oxygen support." | 8.80 | Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates. ( Nahata, MC; Pai, VB, 2000) |
| "To evaluate the association between furosemide exposure and risk of bronchopulmonary dysplasia (BPD)." | 7.91 | Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. ( Benjamin, DK; Clark, RH; Gayam, S; Gorham, D; Greenberg, RG; Laughon, M; Savage, D; Sholomon, A; Smith, PB; Tong, A, 2019) |
| "To assess urinary aldosterone excretion (UAE) and electrolytic balance in very low-birth weight (VLBW) infants who received chronic therapy with furosemide and to compare them with those of infants who did not receive diuretic therapy." | 7.77 | Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants. ( Costa, S; Cota, F; Gallini, F; Latella, C; Maggio, L; Romagnoli, C, 2011) |
| "Ten premature infants with hyaline membrane disease and with acute oliguria were treated with furosemide or furosemide and dopamine." | 7.67 | Acute oliguria in preterm infants with hyaline membrane disease: interaction of dopamine and furosemide. ( Seri, I; Tulassay, T, 1986) |
| "Furosemide is a commonly used loop diuretic in neonatal intensive care." | 6.44 | Furosemide and acute kidney injury in neonates. ( Moghal, NE; Shenoy, M, 2008) |
| "Early data indicate that nephrocalcinosis resolves in approximately 50% of premature infants 5 to 6 months after discontinuation of furosemide." | 5.08 | The natural history of nephrocalcinosis in premature infants treated with loop diuretics. ( Brock, JW; Klein, AM; Pope, JC; Trusler, LA; Walsh, WF; Yared, A, 1996) |
| "0 mg of nebulized furosemide per kilogram of body weight on pulmonary functions were studied in eight preterm infants with bronchopulmonary dysplasia who were supported by mechanical ventilation." | 5.07 | Nebulized furosemide in infants with bronchopulmonary dysplasia. ( Ajayi, OA; Luayon, M; Pildes, RS; Rastogi, A, 1994) |
| "To review the efficacy and safety of inhaled furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia (BPD) in preterm neonates receiving ventilator and oxygen support." | 4.80 | Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates. ( Nahata, MC; Pai, VB, 2000) |
| "To evaluate the association between furosemide exposure and risk of bronchopulmonary dysplasia (BPD)." | 3.91 | Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. ( Benjamin, DK; Clark, RH; Gayam, S; Gorham, D; Greenberg, RG; Laughon, M; Savage, D; Sholomon, A; Smith, PB; Tong, A, 2019) |
| "To assess urinary aldosterone excretion (UAE) and electrolytic balance in very low-birth weight (VLBW) infants who received chronic therapy with furosemide and to compare them with those of infants who did not receive diuretic therapy." | 3.77 | Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants. ( Costa, S; Cota, F; Gallini, F; Latella, C; Maggio, L; Romagnoli, C, 2011) |
| "Ten premature infants with hyaline membrane disease and with acute oliguria were treated with furosemide or furosemide and dopamine." | 3.67 | Acute oliguria in preterm infants with hyaline membrane disease: interaction of dopamine and furosemide. ( Seri, I; Tulassay, T, 1986) |
| " The probable mechanism of stone formation was hypercalciuria due to furosemide therapy (nine patients) and congenital hyperparathyroidism (one patient)." | 3.67 | Nephrolithiasis in premature infants. ( Fernal, W; Gilsanz, V; Ramos, A; Reid, BS; Stanley, P, 1985) |
| " Four had severe hyaline membrane disease and one had chronic bronchopulmonary dysplasia; all received furosemide." | 3.66 | Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. ( Demers, LM; Friedman, Z; Maisels, MJ; Marks, KH; Uhrmann, S, 1978) |
| "Pulmonary edema has been demonstrated in the early stages of respiratory distress syndrome in premature infants." | 2.65 | Early furosemide therapy in premature infants (less than or equal to 2000 gm) with respiratory distress syndrome: a randomized controlled trial. ( Leu, ST; Pildes, RS; Raval, D; Shibli, A; Yeh, TF, 1984) |
| "Furosemide is a commonly used loop diuretic in neonatal intensive care." | 2.44 | Furosemide and acute kidney injury in neonates. ( Moghal, NE; Shenoy, M, 2008) |
| ", washout period and delivery of furosemide to distal airways, and (2) to assess the effects of chronic administration of aerosolized furosemide on mortality, O2 dependency, ventilator dependency, length of hospital stay and long-term outcome." | 2.43 | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA; Yong, W, 2006) |
| " Not enough information is available to assess the effect of chronic administration of aerosolized furosemide on oxygenation and pulmonary mechanics." | 2.41 | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA; Yong, W, 2000) |
| "In preterm infants > 3 weeks of age with CLD, acute and chronic administration of furosemide improve lung compliance." | 2.41 | Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA, 2000) |
| " Not enough information is available to assess the effect of chronic administration of aerosolized furosemide on oxygenation and pulmonary mechanics." | 2.41 | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA; Yong, W, 2001) |
| "Furosemide dosing practices in the NICU are similar across PMA groups, despite maturational changes in drug disposition." | 1.72 | Association between postmenstrual age and furosemide dosing practices in very preterm infants. ( Bamat, NA; Clark, RH; Eichenwald, EC; Greenberg, RG; Hornik, CP; Lang, JE; Laughon, MM; Lorch, SA; Smith, PB; Thompson, EJ; Tolia, VN; Zuppa, AF, 2022) |
| "Furosemide was prescribed to 4055 (9%) infants." | 1.48 | Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight. ( Bell, N; Clark, RH; Crowell, A; Greenberg, RG; Harrison, L; Hornik, CP; Kumar, K; Laughon, M; Scales, G; Shaw, L; Smith, PB; Thompson, EJ, 2018) |
| "Doxapram-treated infants were significantly younger and had a lower birth weight." | 1.39 | Doxapram and hypokalaemia in very preterm infants. ( Ferdynus, C; Fischer, C; Gouyon, JB; Semama, DS, 2013) |
| " All 12 children but 2 continued to receive furosemide for their chronic lung disease demonstrating significant association between chronic use of loop diuretics and persistence fo the renal calcifications (p less than 0." | 1.28 | Furosemide-related renal calcifications in the premature infant. A longitudinal ultrasonographic study. ( Alon, U; Daily, DK; Downing, GJ; Egelhoff, JC, 1991) |
| "Though the coexistence of nephrolithiasis and cholelithiasis in premature infants is extremely rare, we report four patients seen in a two year period." | 1.28 | Coexisting nephrolithiasis and cholelithiasis in premature infants. ( Blickman, JG; Cleveland, RH; Herrin, JT; Jaramillo, D, 1991) |
| "Thirty-five neonates with sensorineural hearing loss (SNHL), identified by brainstem auditory evoked response (BAER), and 70 matched controls with normal BAERs were studied." | 1.28 | Neonatal sensorineural hearing loss associated with furosemide: a case-control study. ( Brown, DR; Sabo, D; Watchko, JF, 1991) |
| "Most common is communicating hydrocephalus due to obliterative arachnoiditis." | 1.28 | [Conservative treatment of non-resorptive hydrocephalus in premature infants]. ( Harms, K; Herting, E; Speer, CP; Stephani, U, 1989) |
| "Renal calculi were seen in four patients, sonographically demonstrated as echogenic foci in the dependent portion of the collecting system, usually accompanied by acoustic shadowing." | 1.27 | Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy. ( Adelman, RD; Goetzman, BW; McGahan, JP; Myracle, MR, 1986) |
| "Cholelithiasis is very rare in the newborn infant and is usually not recognized until surgery or autopsy following perforation of the biliary tree." | 1.26 | Neonatal cholelithiasis. ( Brill, PW; Rosen, MS; Winchester, P, 1982) |
| "All developed clinical signs of hydrocephalus after 2 weeks of age." | 1.26 | Posthemorrhagic hydrocephalus in the preterm infant. ( Chaplin, ER; Goldstein, GW; Hunt, JV; Myerberg, DZ; Tooley, WH, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (47.83) | 18.7374 |
| 1990's | 15 (21.74) | 18.2507 |
| 2000's | 11 (15.94) | 29.6817 |
| 2010's | 8 (11.59) | 24.3611 |
| 2020's | 2 (2.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bamat, NA | 1 |
| Thompson, EJ | 2 |
| Greenberg, RG | 3 |
| Lorch, SA | 1 |
| Zuppa, AF | 1 |
| Eichenwald, EC | 1 |
| Tolia, VN | 1 |
| Clark, RH | 3 |
| Smith, PB | 3 |
| Hornik, CP | 2 |
| Lang, JE | 1 |
| Laughon, MM | 1 |
| Dudley, S | 1 |
| Sen, S | 1 |
| Hanson, A | 1 |
| El Khuffash, A | 1 |
| Levy, PT | 1 |
| Kumar, K | 1 |
| Laughon, M | 2 |
| Crowell, A | 1 |
| Shaw, L | 1 |
| Harrison, L | 1 |
| Scales, G | 1 |
| Bell, N | 1 |
| Gayam, S | 1 |
| Savage, D | 1 |
| Tong, A | 1 |
| Gorham, D | 1 |
| Sholomon, A | 1 |
| Benjamin, DK | 1 |
| Fischer, C | 1 |
| Ferdynus, C | 1 |
| Gouyon, JB | 1 |
| Semama, DS | 1 |
| Gimpel, C | 1 |
| Krause, A | 1 |
| Franck, P | 1 |
| Krueger, M | 1 |
| von Schnakenburg, C | 1 |
| Costa, S | 1 |
| Cota, F | 1 |
| Romagnoli, C | 1 |
| Latella, C | 1 |
| Maggio, L | 1 |
| Gallini, F | 1 |
| Chang, HY | 1 |
| Hsu, CH | 1 |
| Tsai, JD | 1 |
| Li, ST | 1 |
| Hung, HY | 1 |
| Kao, HA | 1 |
| Chang, JH | 1 |
| Chung, HY | 1 |
| Wang, HK | 1 |
| Stewart, A | 1 |
| Brion, LP | 9 |
| Segar, JL | 1 |
| Rais-Bahrami, K | 1 |
| Majd, M | 1 |
| Veszelovszky, E | 1 |
| Short, BL | 1 |
| Primhak, RA | 6 |
| Yong, W | 3 |
| Moghal, NE | 1 |
| Shenoy, M | 1 |
| Green, TP | 1 |
| Thompson, TR | 1 |
| Johnson, DE | 1 |
| Lock, JE | 1 |
| Yeh, TF | 3 |
| Shibli, A | 1 |
| Leu, ST | 1 |
| Raval, D | 1 |
| Pildes, RS | 4 |
| de Sarasqueta, P | 1 |
| Segura-Roldán, MA | 1 |
| Valls, M | 1 |
| Lozano-González, CH | 1 |
| Venkataraman, PS | 1 |
| Han, BK | 1 |
| Tsang, RC | 1 |
| Daugherty, CC | 1 |
| Whitington, PF | 1 |
| Black, DD | 1 |
| Goldsmith, MA | 1 |
| Bhatia, SS | 1 |
| Kanto, WP | 2 |
| Kutner, MH | 1 |
| Rudman, D | 1 |
| Brill, PW | 1 |
| Winchester, P | 1 |
| Rosen, MS | 1 |
| Wilks, A | 2 |
| Singh, J | 1 |
| Betkerur, M | 1 |
| Lilien, L | 1 |
| Hufnagle, KG | 1 |
| Khan, SN | 1 |
| Penn, D | 1 |
| Cacciarelli, A | 1 |
| Williams, P | 1 |
| Jaso, E | 1 |
| Tejedor, JC | 1 |
| Quero, J | 1 |
| Pérez Rodríguez, J | 1 |
| Agustí, B | 1 |
| Castro, J | 1 |
| García Frías, E | 1 |
| Aranda, JV | 2 |
| Lambert, C | 1 |
| Perez, J | 1 |
| Turmen, T | 1 |
| Sitar, DS | 1 |
| Tulassay, T | 2 |
| Kiszel, J | 1 |
| Machay, T | 1 |
| Sembery, P | 1 |
| Chaplin, ER | 1 |
| Goldstein, GW | 1 |
| Myerberg, DZ | 1 |
| Hunt, JV | 1 |
| Tooley, WH | 1 |
| Mercuri, E | 1 |
| Faundez, JC | 1 |
| Cowan, F | 1 |
| Dubowitz, L | 1 |
| Robbins, C | 1 |
| Green, R | 1 |
| Lasker, M | 1 |
| Wiseman, G | 1 |
| Holzman, IR | 1 |
| Rastogi, A | 1 |
| Luayon, M | 1 |
| Ajayi, OA | 1 |
| Pope, JC | 1 |
| Trusler, LA | 1 |
| Klein, AM | 1 |
| Walsh, WF | 1 |
| Yared, A | 1 |
| Brock, JW | 1 |
| Campfield, T | 1 |
| Braden, G | 1 |
| Flynn-Valone, P | 1 |
| Powell, S | 1 |
| Hack, M | 1 |
| Cohen, AR | 1 |
| Raupp, P | 1 |
| Libenson, MH | 1 |
| Kaye, EM | 1 |
| Rosman, NP | 1 |
| Gilmore, HE | 1 |
| Campbell, DE | 2 |
| Pai, VB | 1 |
| Nahata, MC | 1 |
| Fleiss, PM | 1 |
| Friedman, Z | 1 |
| Demers, LM | 1 |
| Marks, KH | 1 |
| Uhrmann, S | 1 |
| Maisels, MJ | 1 |
| Loggie, JM | 1 |
| Kleinman, LI | 1 |
| Van Maanen, EF | 1 |
| Castile, RG | 1 |
| Kleinberg, F | 1 |
| Conway, JJ | 1 |
| Maizels, M | 1 |
| Downing, GJ | 1 |
| Egelhoff, JC | 1 |
| Daily, DK | 1 |
| Alon, U | 1 |
| Hernanz-Schulman, M | 1 |
| Blickman, JG | 1 |
| Herrin, JT | 1 |
| Cleveland, RH | 1 |
| Jaramillo, D | 1 |
| Brown, DR | 1 |
| Watchko, JF | 1 |
| Sabo, D | 1 |
| Short, A | 1 |
| Shaw, NJ | 1 |
| Weindling, AM | 1 |
| Itami, N | 1 |
| Kawaguti, M | 1 |
| Akutsu, Y | 1 |
| Mizutani, K | 1 |
| Tochimaru, H | 1 |
| Takekoshi, Y | 1 |
| Stephani, U | 1 |
| Harms, K | 1 |
| Herting, E | 1 |
| Speer, CP | 1 |
| Ezzedeen, F | 1 |
| Adelman, RD | 2 |
| Ahlfors, CE | 1 |
| Bunyapen, C | 1 |
| Howell, CG | 1 |
| Myracle, MR | 1 |
| McGahan, JP | 1 |
| Goetzman, BW | 1 |
| Jacinto, JS | 1 |
| Modanlou, HD | 1 |
| Crade, M | 1 |
| Strauss, AA | 1 |
| Bosu, SK | 1 |
| Woolfield, N | 1 |
| Haslam, R | 1 |
| Le Quesne, G | 1 |
| Chambers, HM | 1 |
| Hogg, R | 1 |
| Jureidini, K | 1 |
| Atkinson, SA | 1 |
| Shah, JK | 1 |
| McGee, C | 1 |
| Steele, BT | 1 |
| Chemtob, S | 1 |
| Laudignon, N | 1 |
| Sasyniuk, BI | 1 |
| Seri, I | 1 |
| Luken, J | 1 |
| Gilsanz, V | 1 |
| Fernal, W | 1 |
| Reid, BS | 1 |
| Stanley, P | 1 |
| Ramos, A | 1 |
| Nathan, E | 1 |
| Savage, MO | 1 |
| Baum, JD | 1 |
| Roberton, NR | 1 |
| Pickering, D | 1 |
| Sacrez, R | 1 |
| Geisert, J | 1 |
| Willard, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Retrospective Chart Review Evaluating the Impact of Steroid, Diuretic, and Fluid Use Practice Trends in Extreme Premature Infants at Risk for Bronchopulmonary Dysplasia (BPD) at a Single Center Neonatal Intensive Care Unit[NCT04971694] | 175 participants (Anticipated) | Observational | 2021-09-08 | Recruiting | |||
| Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis[NCT02469597] | Phase 2 | 46 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease[NCT01721655] | Phase 2/Phase 3 | 40 participants (Anticipated) | Interventional | 2012-10-31 | Recruiting | ||
| Simplified Diagnostic Algorithm for Evaluation of Neonates With Prenatally Detected Hydronephrosis[NCT01330511] | 76 participants (Actual) | Observational | 2005-01-31 | Completed | |||
| Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants[NCT00711763] | 1 participants (Actual) | Observational | 2008-07-31 | Terminated (stopped due to failure to recruit more patients and lack of supporting personnel.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02469597)
Timeframe: Participants will be followed for the duration of hospital stay up to 1 week
| Intervention | Days (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | 3.1 |
| Placebo | 3.0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.14 |
| Placebo | 0.2 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.19 |
| Placebo | 0.29 |
(NCT02469597)
Timeframe: Within 72 hours of medication administration
| Intervention | participants (Number) |
|---|---|
| Single Dose of Furosemide | 0 |
| Placebo | 0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -3.7 |
| Placebo | -1.7 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -2.8 |
| Placebo | -5.4 |
15 reviews available for furosemide and Infant, Premature, Diseases
| Article | Year |
|---|---|
The role of furosemide and fluid management for a hemodynamically significant patent ductus arteriosus in premature infants.
Topics: Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Pr | 2022 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Aerosols; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant | 2006 |
Furosemide and acute kidney injury in neonates.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prem | 2008 |
The lung of the premature infant: pathophysiology of disease and newer therapies.
Topics: Aerosols; Furosemide; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, | 1994 |
Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
Topics: Cyclooxygenase Inhibitors; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Indomethacin; I | 2000 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prematur | 2000 |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Aerosols; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant | 2000 |
Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates.
Topics: Administration, Inhalation; Aerosols; Bronchopulmonary Dysplasia; Diuretics; Furosemide; Humans; Inf | 2000 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prematur | 2000 |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Aerosols; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant | 2001 |
Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
Topics: Cyclooxygenase Inhibitors; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Indomethacin; I | 2001 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prematur | 2002 |
Furosemide and vitamin E. Two problem drugs in neonatology.
Topics: Acid-Base Imbalance; Anemia; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Diuresis; Ductus Arter | 1986 |
7 trials available for furosemide and Infant, Premature, Diseases
| Article | Year |
|---|---|
Diuresis and pulmonary function in premature infants with respiratory distress syndrome.
Topics: Chlorothiazide; Clinical Trials as Topic; Diuresis; Ductus Arteriosus, Patent; Furosemide; Humans; I | 1983 |
Early furosemide therapy in premature infants (less than or equal to 2000 gm) with respiratory distress syndrome: a randomized controlled trial.
Topics: Bronchopulmonary Dysplasia; Clinical Trials as Topic; Ductus Arteriosus, Patent; Furosemide; Humans; | 1984 |
Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
Topics: Drug Therapy, Combination; Ductus Arteriosus, Patent; Furosemide; Humans; Indomethacin; Infant, Newb | 1982 |
Nebulized furosemide in infants with bronchopulmonary dysplasia.
Topics: Airway Resistance; Body Weight; Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Female | 1994 |
The natural history of nephrocalcinosis in premature infants treated with loop diuretics.
Topics: Diuretics; Follow-Up Studies; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Long | 1996 |
International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group.
Topics: Acetazolamide; Cerebral Hemorrhage; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Diuretics; Drug | 1998 |
Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn.
Topics: Acetazolamide; Cerebral Hemorrhage; Cerebrospinal Fluid Shunts; Diuretics; Drainage; Drug Therapy, C | 1999 |
47 other studies available for furosemide and Infant, Premature, Diseases
| Article | Year |
|---|---|
Association between postmenstrual age and furosemide dosing practices in very preterm infants.
Topics: Fetal Growth Retardation; Furosemide; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Pr | 2022 |
Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight.
Topics: Ductus Arteriosus, Patent; Female; Furosemide; Hospitalization; Humans; Infant, Newborn; Infant, Pre | 2018 |
Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Drug Administration Schedule; Female; Furosemide; Gestatio | 2019 |
Doxapram and hypokalaemia in very preterm infants.
Topics: Analysis of Variance; Apnea; Diuretics; Doxapram; Female; Furosemide; Humans; Hypokalemia; Infant, E | 2013 |
Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.
Topics: Birth Weight; Calcium; Creatine; Diuretics; Female; Furosemide; Gestational Age; Humans; Infant, New | 2010 |
Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants.
Topics: Aldosterone; Birth Weight; Chlorides; Diuretics; Furosemide; Gestational Age; Humans; Infant, Newbor | 2011 |
Renal calcification in very low birth weight infants.
Topics: Anti-Inflammatory Agents; Dexamethasone; Diuretics; Furosemide; Humans; Incidence; Infant, Newborn; | 2011 |
Use of furosemide and hearing loss in neonatal intensive care survivors.
Topics: Auditory Threshold; Brain Stem; Deafness; District of Columbia; Diuretics; Female; Furosemide; Heari | 2004 |
[Echocardiographic study of the persistence of the ductus arteriosus in premature newborn infants].
Topics: Digoxin; Ductus Arteriosus, Patent; Echocardiography; Furosemide; Humans; Infant, Newborn; Infant, P | 1984 |
Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy.
Topics: Bone and Bones; Bone Diseases; Calcium; Furosemide; Humans; Hyperparathyroidism, Secondary; Infant, | 1983 |
Cholelithiasis in premature infants treated with parenteral nutrition and furosemide.
Topics: Bronchi; Cholelithiasis; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung; Par | 1980 |
Gluconate calcium therapy and neonatal hypercalciuria.
Topics: Calcium; Calcium Gluconate; Creatinine; Ductus Arteriosus, Patent; Furosemide; Gluconates; Humans; I | 1981 |
Neonatal cholelithiasis.
Topics: Cholelithiasis; Female; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Parenteral | 1982 |
Renal calcifications: a complication of long-term furosemide therapy in preterm infants.
Topics: Ductus Arteriosus, Patent; Furosemide; Heart Failure; Humans; Infant; Infant, Newborn; Infant, Prema | 1982 |
[Treatment of patent ductus arteriosus in preterm infants].
Topics: Digoxin; Ductus Arteriosus, Patent; Female; Furosemide; Humans; Indomethacin; Infant, Low Birth Weig | 1982 |
Metabolism and renal elimination of furosemide in the newborn infant.
Topics: Female; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Kidney; Male; Time Factors | 1982 |
[Effect of furosemide on kidney function in premature infants].
Topics: Diuresis; Diuretics; Furosemide; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseas | 1981 |
Posthemorrhagic hydrocephalus in the preterm infant.
Topics: Acetazolamide; Brain Damage, Chronic; Cerebral Hemorrhage; Cerebrospinal Fluid Shunts; Child; Child, | 1980 |
Acetazolamide without frusemide in the treatment of post-haemorrhagic hydrocephalus.
Topics: Acetazolamide; Administration, Oral; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Drug Adm | 1994 |
Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants.
Topics: Analysis of Variance; Calcium; Diuretics; Furosemide; Gestational Age; Humans; Infant, Newborn; Infa | 1997 |
Acetazolamide plus furosemide for periventricular dilatation: lessons for drug therapy in children.
Topics: Acetazolamide; Cerebral Hemorrhage; Cerebral Ventricles; Diuretics; Drug Therapy, Combination; Furos | 1998 |
Acetazolamide in posthaemorrhagic ventricular dilatation.
Topics: Acetazolamide; Cerebral Hemorrhage; Cerebral Ventricles; Diuretics; Drug Therapy, Combination; Furos | 1998 |
Hypophosphatemic rickets and breast milk.
Topics: Breast Feeding; Female; Furosemide; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Ph | 1979 |
Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants.
Topics: Calcium; Drug Antagonism; Ductus Arteriosus, Patent; Female; Furosemide; Humans; Hyaline Membrane Di | 1978 |
Renal function and diuretic therapy in infants and children. Part III.
Topics: Adolescent; Calcium; Child; Child, Preschool; Diuresis; Diuretics; Edema; Ethacrynic Acid; Female; F | 1975 |
The pathogenesis and management of massive pulmonary hemorrhage in the neonate. Case report of a normal survivor.
Topics: Asphyxia; Atropine; Blood Transfusion; Furosemide; Heart Failure; Hemorrhage; Humans; Infant, Newbor | 1976 |
The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Counc
Topics: Data Interpretation, Statistical; Diuresis; Furosemide; Humans; Hydronephrosis; Infant; Infant, Newb | 1992 |
Furosemide-related renal calcifications in the premature infant. A longitudinal ultrasonographic study.
Topics: Child, Preschool; Female; Follow-Up Studies; Furosemide; Humans; Infant; Infant, Low Birth Weight; I | 1991 |
Hyperechoic renal medullary pyramids in infants and children.
Topics: Child; Furosemide; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Ki | 1991 |
Coexisting nephrolithiasis and cholelithiasis in premature infants.
Topics: Bronchopulmonary Dysplasia; Cholelithiasis; Female; Furosemide; Humans; Infant, Newborn; Infant, Pre | 1991 |
Neonatal sensorineural hearing loss associated with furosemide: a case-control study.
Topics: Auditory Threshold; Brain Stem; Child, Preschool; Deafness; Evoked Potentials, Auditory, Brain Stem; | 1991 |
Nephrocalcinosis and phosphate supplementation in a preterm infant.
Topics: Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Nephrocalcinosis; Phosphates | 1990 |
Renal calcifications in preterm infants.
Topics: Acetazolamide; Furosemide; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Dis | 1989 |
[Conservative treatment of non-resorptive hydrocephalus in premature infants].
Topics: Acetazolamide; Cerebral Hemorrhage; Cerebrospinal Fluid Shunts; Combined Modality Therapy; Fluid The | 1989 |
Renal calcification in preterm infants: pathophysiology and long-term sequelae.
Topics: Birth Weight; Calcium; Chronic Disease; Follow-Up Studies; Furosemide; Humans; Infant, Newborn; Infa | 1988 |
Cholecystitis in a preterm infant.
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cholecystitis; Cholelithiasis; Diagnosis, Differe | 1986 |
Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy.
Topics: Bone and Bones; Bone Diseases; Calcinosis; Chronic Disease; Furosemide; Humans; Infant; Infant, Low | 1986 |
Renal calcification incidence in very low birth weight infants.
Topics: Calcinosis; Calcium; Creatinine; Furosemide; Humans; Infant, Low Birth Weight; Infant, Newborn; Infa | 1988 |
Ultrasound diagnosis of nephrocalcinosis in preterm infants.
Topics: Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Nephrocalcinosis; Ultrasonography | 1988 |
Mineral excretion in premature infants receiving various diuretic therapies.
Topics: Birth Weight; Bone Diseases, Metabolic; Diuretics; Drug Therapy, Combination; Female; Furosemide; Hu | 1988 |
Acute oliguria in preterm infants with hyaline membrane disease: interaction of dopamine and furosemide.
Topics: Anuria; Creatinine; Diuresis; Dopamine; Drug Interactions; Drug Therapy, Combination; Furosemide; Hu | 1986 |
Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
Topics: Anuria; Drug Therapy, Combination; Ductus Arteriosus, Patent; Furosemide; Humans; Indomethacin; Infa | 1986 |
Nephrolithiasis in premature infants.
Topics: Female; Furosemide; Humans; Hyperparathyroidism; Infant, Low Birth Weight; Infant, Newborn; Infant, | 1985 |
Severe hydrops foetalis treated with peritoneal dialysis and positive-pressure ventilation.
Topics: Erythroblastosis, Fetal; Female; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; P | 1968 |
Proceedings: Frusemide therapy in infants with respiratory distress syndrome.
Topics: Calcium; Carbon Dioxide; Diuretics; Furosemide; Humans; Hydrogen-Ion Concentration; Infant, Newborn; | 1974 |
Frusemide for cardiac failure in infancy.
Topics: Anemia; Aortic Coarctation; Blood Transfusion; Furosemide; Heart Failure; Humans; Infant, Newborn; I | 1969 |
[Place of new diuretics in the treatment of some neonatal diseases].
Topics: Brain Edema; Diuresis; Edema; Ethacrynic Acid; Furosemide; Humans; Infant, Newborn; Infant, Newborn, | 1969 |